Study Shows Tysabri Reduces Risk of Cognitive Decline for Pediatric-Onset Multiple Sclerosis Patients

The Gap Tysabri is a therapy that has shown efficacy for reducing disease activity in patients diagnosed with pediatric-onset multiple sclerosis (POMS). Previous investigations have indicated that up to 58%…

Continue Reading Study Shows Tysabri Reduces Risk of Cognitive Decline for Pediatric-Onset Multiple Sclerosis Patients
This Former College Basketball Star Refuses to Quit After Being Diagnosed with Multiple Sclerosis
12019 / Pixabay

This Former College Basketball Star Refuses to Quit After Being Diagnosed with Multiple Sclerosis

According to a story from patch.com, the life of Jasmine Matthews has been defined by the sport of basketball. "Jazz" first gained fame for her skills on the court when…

Continue Reading This Former College Basketball Star Refuses to Quit After Being Diagnosed with Multiple Sclerosis

Study Finds Prices for Multiple Sclerosis Drugs are Going Up: We Need to Do Better

There are currently 11 treatment options for multiple sclerosis (MS) in the United States. Some of these are symptomatic treatments, and some actually slow progression of the disease. Before 2009…

Continue Reading Study Finds Prices for Multiple Sclerosis Drugs are Going Up: We Need to Do Better
Michigan Researchers to Study Neurofilament Light Chain Blood Levels as a Predictor of Multiple Sclerosis
source: pixabay.com

Michigan Researchers to Study Neurofilament Light Chain Blood Levels as a Predictor of Multiple Sclerosis

According to a publication from BioSpace, researchers from Michigan's Memorial Healthcare Institute for Neurosciences and Multiple Sclerosis are taking full advantage of recent technological advances in neurofilament light chain testing…

Continue Reading Michigan Researchers to Study Neurofilament Light Chain Blood Levels as a Predictor of Multiple Sclerosis
Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs
qimono / Pixabay

Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs

According to a story from sectorpublishingintelligence.co.uk, studies utilizing data gathered in the real-world treatment setting are highlighting the characteristics of two different therapies for multiple sclerosis (MS) developed by the…

Continue Reading Biogen Releases The Latest Research Results Featuring its Multiple Sclerosis Drugs
First Human Trial Completed for Experimental Scleroderma and Multiple Sclerosis Drug
stevepb / Pixabay

First Human Trial Completed for Experimental Scleroderma and Multiple Sclerosis Drug

According to a story from Financial Buzz, the drug developer Emerald Health Pharmaceuticals, Inc., recently announced that the company had completed a phase 1 clinical trial for its experimental drug…

Continue Reading First Human Trial Completed for Experimental Scleroderma and Multiple Sclerosis Drug
This Multiple Sclerosis Patient is Taking Charge of Her Diagnosis by Working at Her Treatment Center
Free-Photos / Pixabay

This Multiple Sclerosis Patient is Taking Charge of Her Diagnosis by Working at Her Treatment Center

According to a story from Oklahoma's Nursing Times, Chrissy Brady was surprised one day when she began to lose feeling in her left leg. Then, for the next month, she…

Continue Reading This Multiple Sclerosis Patient is Taking Charge of Her Diagnosis by Working at Her Treatment Center
Potential Treatment for Multiple Sclerosis Demonstrates Good Safety and Tolerability in Early Trial
stevepb / Pixabay

Potential Treatment for Multiple Sclerosis Demonstrates Good Safety and Tolerability in Early Trial

According to a story from news.cision.com, the Swedish biotechnology company Cyxone recently announced positive results from the company's phase 1 clinical trial. This trial was testing the tolerability and safety…

Continue Reading Potential Treatment for Multiple Sclerosis Demonstrates Good Safety and Tolerability in Early Trial
Vaccinations Do Not Increase the Risk of Getting Multiple Sclerosis, Study Finds
whitesession / Pixabay

Vaccinations Do Not Increase the Risk of Getting Multiple Sclerosis, Study Finds

According to a story from EurekAlert!, a recent study has found that vaccinations are not a risk factor for multiple sclerosis. A risk factor is something that could potentially increase…

Continue Reading Vaccinations Do Not Increase the Risk of Getting Multiple Sclerosis, Study Finds

First Participant Dosed in Phase 1 Clinical Trial for Investigational Therapy for Multiple Sclerosis

Cyxone has just announced that the first person has been dosed in their Phase 1 clinical trial for Multiple Sclerosis (MS). This trial is investigating the effect of T20K. It…

Continue Reading First Participant Dosed in Phase 1 Clinical Trial for Investigational Therapy for Multiple Sclerosis